Prostacyclin therapy in peripheral arterial disease-Reference-Cited by-同舟云学术

Prostacyclin therapy in peripheral arterial disease

Published:1980-07 Issue:1-2 Volume:19 Page:191-199
ISSN:0049-3848
Container-title:Thrombosis Research
language:en
Short-container-title:Thrombosis Research

Author:

Szczeklik A.,Gryglewski R.J.,Niż;ankowski R.,Skawiński S.,Głuszko P.,Korbut R.

Publisher

Elsevier BV

Subject

Hematology

Reference14 articles.

1. An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation;Moncada;Nature,1976

2. Arterial walls are protected against deposition of platelet thrombi by a substance /Prostaglandin X/ which they make from prostaglandin endoperoxides;Gryglewski;Prostaglandins,1976

3. Prostacyclin and thromboxane A2 biosynthesis capacities of heart, arteries and platelets at various stages of experimental atherosclerosis in rabbits;Gryglewski;Atherosclerosis,1978

4. Inhibition of prostacyclin formation by lipid peroxides in the arterial wall: hypothetical step in development of atherosclerosis;Gryglewski;Materia Med. Pol.,1978

5. Prostacyclin generation in atherosclerotic arteries;Sinzinger;Lancet,1979

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antithrombotic Effects of Pyridinium Compounds Formed from Trigonelline upon Coffee Roasting;Journal of Agricultural and Food Chemistry;2014-03-20

2. Treatment of Patients with Thromboangiitis Obliterans with Cyclophosphamide;Angiology;2001-06

3. Angiotensin II mediates systemic rebound hypertension after cessation of prostacyclin infusion in sheep;Journal of Applied Physiology;1998-08-01

4. Systemic and pulmonary hypertension after abrupt cessation of prostacyclin: role of thromboxane A2;Journal of Applied Physiology;1996-01-01

5. A New Derivative of Trapidil (AR 12456) as a Potentially New Antiatherosclerotic Drug;Cardiovascular Drug Reviews;1991-12